Literature DB >> 18636750

Formation of the full SNARE complex eliminates interactions of its individual protein components with the Kv2.1 channel.

Sharon Tsuk1, Anatoli Lvov, Izhak Michaelevski, Dodo Chikvashvili, Ilana Lotan.   

Abstract

Previously, we have demonstrated physical and functional interactions of the voltage-gated potassium channel Kv2.1 with the plasma membrane protein components of the exocytotic SNARE complex, syntaxin 1A, and the t-SNARE, syntaxin 1A/SNAP-25, complex. Importantly, the physical interaction of Kv2.1 with syntaxin was shown to be involved in the facilitation of secretion from PC12 cells, which was independent of potassium currents. Recently, we showed that also VAMP2, the vesicular SNARE, interacts physically and functionally with Kv2.1. Here, we first set out to test the interaction of the full SNARE, syntaxin/SNAP-25/VAMP2, complex with the channel. Using the interaction of VAMP2 with Kv2.1 in Xenopus oocytes as a probe, we showed that coexpression of the t-SNARE complex with VAMP2 abolished the VAMP2 effect on channel inactivation and reduced the amount of VAMP2 that coprecipitated with Kv2.1. Further, in vitro pull down assays showed that the full SNARE complex failed to interact with Kv2.1 N- and C-termini in tandem, in contrast to the individual SNARE components. This suggests that the interactions of the SNARE components with Kv2.1 are abolished upon their recruitment into a full SNARE complex, which does not interact with the channel. Other important findings arising from the in vitro study are that the t-SNARE complex, in addition to syntaxin, interacts with a specific C-terminal channel domain, C1a, shown to mediate the facilitation of release by Kv2.1 and that the presence of Kv2.1 N-terminus has crucial contribution to these interactions. These findings provide important insights into the understanding of the complex molecular events involved in the novel phenomenon of secretion facilitation in neuroendocrine cells by Kv2.1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636750     DOI: 10.1021/bi800512p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Rearrangements in the relative orientation of cytoplasmic domains induced by a membrane-anchored protein mediate modulations in Kv channel gating.

Authors:  Anatoli Lvov; Dafna Greitzer; Shai Berlin; Dodo Chikvashvili; Sharon Tsuk; Ilana Lotan; Izhak Michaelevski
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

2.  K+ Channel-SEC11 Binding Exchange Regulates SNARE Assembly for Secretory Traffic.

Authors:  Sakharam Waghmare; Cecile Lefoulon; Ben Zhang; Edita Liliekyte; Naomi Donald; Michael R Blatt
Journal:  Plant Physiol       Date:  2019-09-23       Impact factor: 8.340

3.  SNAP-25 is abundantly expressed in enteric neuronal networks and upregulated by the neurotrophic factor GDNF.

Authors:  M Barrenschee; M Böttner; J Harde; C Lange; F Cossais; M Ebsen; I Vogel; T Wedel
Journal:  Histochem Cell Biol       Date:  2015-02-06       Impact factor: 4.304

4.  VAMP721 Conformations Unmask an Extended Motif for K+ Channel Binding and Gating Control.

Authors:  Ben Zhang; Rucha Karnik; Sakharam Waghmare; Naomi Donald; Michael R Blatt
Journal:  Plant Physiol       Date:  2016-11-07       Impact factor: 8.340

5.  The Arabidopsis R-SNARE VAMP721 Interacts with KAT1 and KC1 K+ Channels to Moderate K+ Current at the Plasma Membrane.

Authors:  Ben Zhang; Rucha Karnik; Yizhou Wang; Niklas Wallmeroth; Michael R Blatt; Christopher Grefen
Journal:  Plant Cell       Date:  2015-05-22       Impact factor: 11.277

Review 6.  Development of brain ventricular system.

Authors:  Vladimir Korzh
Journal:  Cell Mol Life Sci       Date:  2017-08-05       Impact factor: 9.261

7.  Vesicle-associated membrane protein 2 (VAMP2) but Not VAMP3 mediates cAMP-stimulated trafficking of the renal Na+-K+-2Cl- co-transporter NKCC2 in thick ascending limbs.

Authors:  Paulo S Caceres; Mariela Mendez; Pablo A Ortiz
Journal:  J Biol Chem       Date:  2014-07-09       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.